Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

41.34
Delayed Data
As of Feb 17
 +0.42 / +1.03%
Today’s Change
37.20
Today|||52-Week Range
45.58
+7.35%
Year-to-Date
If You Want Yield, Look to the UK
Feb 19 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi
Feb 10 / Zacks.com - Paid Partner Content
2 High-Yield Dividend Stocks That Are Ridiculously Cheap
Feb 18 / MotleyFool.com - Paid Partner Content
Glaxo (GSK) Beats on Q4 Earnings, Posts Dismal '17 View
Feb 09 / Zacks.com - Paid Partner Content
Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View
Feb 17 / Zacks.com - Paid Partner Content
Strong Q4 Earnings Ahead of the Bell: TWX, GSK, ALK
Feb 08 / Zacks.com - Paid Partner Content
Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook
Feb 16 / Zacks.com - Paid Partner Content
Glaxo (GSK) Misses Q4 Earnings, Revenues Rise Y/Y
Feb 08 / Zacks.com - Paid Partner Content
Alkermes (ALKS) Q4 Loss Narrower than Expectations, Sales Beat
Feb 16 / Zacks.com - Paid Partner Content
Amgen's Secondary Hyperparathyroidism Drug Approved in U.S.
Feb 08 / Zacks.com - Paid Partner Content
Alexion (ALXN) Q4 Earnings In-Line, Sales Rise Y/Y
Feb 16 / Zacks.com - Paid Partner Content
GW Pharma (GWPH) Posts Narrower-than-Expected Loss in Q1
Feb 08 / Zacks.com - Paid Partner Content
AMAG Pharma (AMAG) Incurs Loss in Q4, Revenues Lag Estimates
Feb 15 / Zacks.com - Paid Partner Content
Drug Stock Q4 Earnings to Watch on Feb 8: AGN, GSK & More
Feb 07 / Zacks.com - Paid Partner Content
Drug Stocks Q4 Earnings Slated for Feb 16: ALXN, ZTS & More
Feb 15 / Zacks.com - Paid Partner Content
Better Buy: Merck & Co. Inc. vs. GlaxoSmithKline
Feb 07 / MotleyFool.com - Paid Partner Content
13-F Summary: Who Bought And Sold What In The Fourth Quarter
Feb 15 / Investing Channel - Paid Partner Content
GM drives into earnings season; BP shares drop; Stocks steady
Feb 07 / CNNMoney.com
Gilead (GILD) Announces Data on Combination Therapy for HIV
Feb 14 / Zacks.com - Paid Partner Content
Earnings season; Tiffany shakeup; Takata buyer?
Feb 06 / CNNMoney.com
GlaxoSmithKline Performance Continues, but Generic Competition May Finally Be Coming
Feb 14 / MotleyFool.com - Paid Partner Content
Trump's deregulation nation; Silicon Valley tackles immigration ban; Macy's buzz
Feb 05 / CNNMoney.com
Lilly's Olumiant Gets Marketing Authorization in Europe
Feb 14 / Zacks.com - Paid Partner Content